Werbung
Werbung

WVE

WVE logo

Wave Life Sciences Ltd. Ordinary Shares

13.84
USD
Gesponsert
-0.99
-6.68%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

13.95

+0.11
+0.77%

WVE Ergebnisberichte

Positives Überraschungsverhältnis

WVE übertreffen die 9 der letzten 40Schätzungen.

23%

Nächster Bericht

Datum des nächsten Berichts
02. März 2026
Estimate for Q4 25 (Revenue/ EPS)
$17.33M
/
-$0.26
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+127.81%
/
-18.75%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
-79.31%
/
-252.94%

Wave Life Sciences Ltd. Ordinary Shares earnings per share and revenue

On 10. Nov. 2025, WVE reported earnings of -0.32 USD per share (EPS) for Q3 25, missing the estimate of -0.30 USD, resulting in a -6.21% surprise. Revenue reached 7.61 million, compared to an expected 11.24 million, with a -32.32% difference. The market reacted with a -10.31% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 17 analysts forecast an EPS of -0.26 USD, with revenue projected to reach 17.33 million USD, implying an decrease of -18.75% EPS, and increase of 127.81% in Revenue from the last quarter.
FAQ
For Q3 2025, Wave Life Sciences Ltd. Ordinary Shares reported EPS of -$0.32, missing estimates by -6.21%, and revenue of $7.61M, -32.32% below expectations.
The stock price moved down -10.31%, changed from $7.86 before the earnings release to $7.05 the day after.
The next earning report is scheduled for 02. März 2026.
Based on 17 analysts, Wave Life Sciences Ltd. Ordinary Shares is expected to report EPS of -$0.26 and revenue of $17.33M for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung